A 78-year-old man with chronic kidney disease and a recent history of hospitalization for pneumonia, now treated with broad-spectrum antibiotics, develops new-onset diarrhea. Tests confirm Clostridium difficile as the causative agent. Which characteristic of fidaxomicin makes it a preferable choice for this patient with renal impairment?